Works matching IS 1540658X AND DT 2025 AND VI 23 AND IP 2
Results: 4
Development and Characterization of Oral Efavirenz-Loaded Nanostructured Lipid Carriers and Their Optimization with Box–Behnken Design Approach for the Neurological Disorder.
- Published in:
- Assay & Drug Development Technologies, 2025, v. 23, n. 2, p. 84, doi. 10.1089/adt.2024.115
- By:
- Publication type:
- Article
In Silico Screening of Phytochemicals as Potential Inhibitors of the JAK/STATs Pathway in Psoriasis.
- Published in:
- Assay & Drug Development Technologies, 2025, v. 23, n. 2, p. 100, doi. 10.1089/adt.2024.087
- By:
- Publication type:
- Article
Golden Therapeutic Approach to Combat Viral Diseases Using Gold Nanomaterials.
- Published in:
- Assay & Drug Development Technologies, 2025, v. 23, n. 2, p. 70, doi. 10.1089/adt.2024.071
- By:
- Publication type:
- Article
A Pioneer Review on Lactoferrin-Conjugated Extracellular Nanovesicles for Targeting Cellular Melanoma: Recent Advancements and Future Prospects.
- Published in:
- Assay & Drug Development Technologies, 2025, v. 23, n. 2, p. 55, doi. 10.1089/adt.2024.045
- By:
- Publication type:
- Article